{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:08:38Z","timestamp":1794254918922,"version":"4.9.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cyto.2021.155432","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T18:55:04Z","timestamp":1611860104000},"page":"155432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo"],"prefix":"10.1016","volume":"140","author":[{"given":"Mala","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohmmad Shoab","family":"Mansuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4787-2597","authenticated-orcid":false,"given":"Ashlesha","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayantani P.","family":"Palit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh C.","family":"Laddha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheedunnisa","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155432_b0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/138920010791526105","article-title":"Vitiligo: pathogenetic hypotheses and targets for current therapies","volume":"11","author":"Guerra","year":"2010","journal-title":"Current Drug Metab."},{"key":"10.1016\/j.cyto.2021.155432_b0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017046","article-title":"Melanocytes and their diseases","volume":"4","author":"Yamaguchi","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cyto.2021.155432_b0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/jidsymp.2015.14","article-title":"Melanocytes and skin immunity","volume":"17","author":"Hong","year":"2015","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"10.1016\/j.cyto.2021.155432_b0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/1744666X.2019.1550358","article-title":"Cytokines: the yin and yang of vitiligo pathogenesis","volume":"15","author":"Singh","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.cyto.2021.155432_b0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40257-013-0039-3","article-title":"The role of tumor necrosis factor-\u03b1 in the pathogenesis of vitiligo","volume":"14","author":"Camara-Lemarroy","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052298","article-title":"Increased Tumor Necrosis Factor (TNF)-\u03b1 and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo","volume":"7","author":"Laddha","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2021.155432_b0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12103","article-title":"Vitiligo: interplay between oxidative stress and immune system","volume":"22","author":"Laddha","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081736","article-title":"Tumor Necrosis Factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility","volume":"8","author":"Laddha","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2021.155432_b0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/1523-1747.ep12460991","article-title":"Interleukins 1\u03b1 and 6 and tumor necrosis factor-\u03b1 are paracrine inhibitors of human melanocyte proliferation and melanogenesis","volume":"96","author":"Swope","year":"1991","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.cyto.2021.155432_b0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00403-008-0904-8","article-title":"Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients","volume":"301","author":"Namian","year":"2009","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0060","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bjd.14016","article-title":"Tumour necrosis factor-\u03b1 inhibition can stabilize disease in progressive vitiligo","volume":"173","author":"Webb","year":"2015","journal-title":"Brit. J. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2012-201671","article-title":"Autophagy regulates TNF\u03b1-mediated joint destruction in experimental arthritis","volume":"72","author":"Lin","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2021.155432_b0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0560.1984.tb00361.x","article-title":"Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects","volume":"11","author":"Uda","year":"1984","journal-title":"J. Cutaneous Pathol."},{"key":"10.1016\/j.cyto.2021.155432_b0075","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4172\/2161-1009.1000273","article-title":"Interleukin 1-\u03b1: A modulator of melanocyte homeostasis in vitiligo","volume":"5","author":"Singh","year":"2016","journal-title":"Biochem. Anal. Biochem."},{"key":"10.1016\/j.cyto.2021.155432_b0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cyto.2021.155432_b0085","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1751-1097.2007.00228.x","article-title":"Methodology for evaluation of melanin content and production of pigment cells in vitro","volume":"84","author":"Hu","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.cyto.2021.155432_b0090","first-page":"451","article-title":"TNF-\u03b1 regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells","volume":"2015","author":"Prajapati","year":"1852","journal-title":"BBA-Molecular Basis Dis."},{"key":"10.1016\/j.cyto.2021.155432_b0095","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0006-2952(03)00083-2","article-title":"Evaluation of the probes 2\u2032, 7\u2032-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation","volume":"65","author":"Myhre","year":"2003","journal-title":"Biochemical Pharmacol."},{"key":"10.1016\/j.cyto.2021.155432_b0100","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cyto.2021.155432_b0105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/bj20021121","article-title":"Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD (P)+ oxidation\u2013reduction state","volume":"368","author":"Kushnareva","year":"2002","journal-title":"Biochemical J."},{"key":"10.1016\/j.cyto.2021.155432_b0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1432-1327.1998.2550139.x","article-title":"Mechanisms of melanogenesis inhibition by tumor necrosis factor-\u03b1 in B16\/F10 mouse melanoma cells","volume":"255","author":"Mart\u00ednez Esparza","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cyto.2021.155432_b0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1523-1747.ep12478093","article-title":"Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines","volume":"95","author":"Yohn","year":"1990","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/path.1711690205","article-title":"Abnormal expression of MHC class II and ICAM1 by melanocytes in vitiligo","volume":"169","author":"Al Badri","year":"1993","journal-title":"J. Pathol."},{"key":"10.1016\/j.cyto.2021.155432_b0125","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/10715762.2017.1402303","article-title":"Levels of oxidative damage and proinflammatory cytokines are enhanced in patients with active vitiligo","volume":"51","author":"Mitra","year":"2017","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.cyto.2021.155432_b0130","first-page":"849","article-title":"Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis","volume":"24","author":"Moretti","year":"2009","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.cyto.2021.155432_b0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to type-1\u2013like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wa\u0144kowicz-Kali\u0144ska","year":"2003","journal-title":"Laboratory Invest."},{"key":"10.1016\/j.cyto.2021.155432_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-13961-5","article-title":"Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin","volume":"7","author":"Dell\u2019Anna","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2021.155432_b0150","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.0022-202x.2001.01459.x","article-title":"Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo","volume":"117","author":"Dell'Anna","year":"2001","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0155","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1034\/j.1600-0749.2003.00087.x","article-title":"Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients","volume":"16","author":"Dell'Anna","year":"2003","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.cyto.2021.155432_b0160","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1089\/ars.2010.3445","article-title":"Apoptosis-inducing factor: structure, function, and redox regulation","volume":"14","author":"Sevrioukova","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cyto.2021.155432_b0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ebiom.2018.03.016","article-title":"Apoptosis-inducing factor (AIF) in physiology and disease: the tale of a repented natural born killer","volume":"30","author":"Bano","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cyto.2021.155432_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","volume":"9","author":"Laddha","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2021.155432_b0175","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/exd.12372","article-title":"Role of oxidative stress and autoimmunity in onset and progression of vitiligo","volume":"23","author":"Laddha","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2003648","article-title":"A direct link between MITF, innate immunity, and hair graying","volume":"16","author":"Harris","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.cyto.2021.155432_b0185","doi-asserted-by":"crossref","first-page":"15132","DOI":"10.1074\/jbc.M200004200","article-title":"Pax3 down-regulation and shut-off of melanogenesis in melanoma B16\/F10 by interleukin-6 receptor signaling","volume":"277","author":"Kamaraju","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2021.155432_b0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1755-148X.2011.00945.x","article-title":"Dysregulation of melanocyte function by Th17 related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris","volume":"25","author":"Kotobuki","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.cyto.2021.155432_b0195","first-page":"1","article-title":"Investigation of the Role of Interleukin 6 in Vitiligo Pathogenesis","author":"Singh","year":"2020","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.cyto.2021.155432_b0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1600-0749.2005.00266.x","article-title":"Inhibition of skin pigmentation by an extract of Lepidium apetalum and its possible implication in IL-6 mediated signaling","volume":"18","author":"Choi","year":"2005","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.cyto.2021.155432_b0205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/1523-1747.ep12472339","article-title":"In vivo cytokine expression in normal and perturbed murine skin\u2014analysis by competitive quantitative polymerase chain reaction","volume":"100","author":"Kilgus","year":"1993","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0210","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2133.1998.02209.x","article-title":"\u0391-melanocyte stimulating hormone inhibits tumour necrosis factor-\u03b1 stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines","volume":"138","author":"Neil","year":"1998","journal-title":"Brit. J. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0215","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1183\/09031936.98.11040949","article-title":"The role of ICAM-1 on T-cells in the pathogenesis of asthma","volume":"11","author":"Stanciu","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cyto.2021.155432_b0220","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1755-148X.2011.00892.x","article-title":"R, Cytotoxic T lymphocyte associated antigen 4 (CTLA4) in isolated vitiligo: a genotype-phenotype correlation","volume":"24","author":"Dwivedi","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.cyto.2021.155432_b0225","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bjd.12467","article-title":"Association of NLRP 1 genetic variants and m RNA overexpression with generalized vitiligo and disease activity in a Gujarat population","volume":"169","author":"Dwivedi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0230","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo","volume":"33","author":"Dwivedi","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cyto.2021.155432_b0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jdermsci.2013.04.026","article-title":"Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients","volume":"71","author":"Dwivedi","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.cyto.2021.155432_b0240","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-Cells and CD4+\/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.cyto.2021.155432_b0245","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1742-4658.2011.08017.x","article-title":"Tumor necrosis factor receptor cross-talk","volume":"278","author":"Naud\u00e9","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.cyto.2021.155432_b0250","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1126\/science.7544915","article-title":"TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40","volume":"269","author":"Rothe","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.cyto.2021.155432_b0255","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fimmu.2013.00478","article-title":"TNF receptor 2 and disease: autoimmunity and regenerative medicine","volume":"4","author":"Faustman","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2021.155432_b0260","doi-asserted-by":"crossref","first-page":"10838","DOI":"10.1074\/jbc.275.15.10838","article-title":"Activation of NF-\u03baB by FADD, Casper, and caspase-8","volume":"275","author":"Hu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2021.155432_b0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/mcbr.2001.0295","article-title":"Crosstalk between NF-\u03baB-activating and apoptosis-inducing proteins of the TNF-receptor complex","volume":"4","author":"Heyninck","year":"2001","journal-title":"Mol. Cell Biol. Res. Commun."},{"key":"10.1016\/j.cyto.2021.155432_b0270","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/jid.2014.439","article-title":"Suppression of autophagy dysregulates the antioxidant response and causes premature senescence of melanocytes","volume":"135","author":"Zhang","year":"2015","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0275","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","article-title":"Physiological roles of mitochondrial reactive oxygen species","volume":"48","author":"Sena","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cyto.2021.155432_b0280","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/jjco\/hyt160","article-title":"Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of Renal Clear Cell Carcinoma","volume":"43","author":"Deng","year":"2013","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2021.155432_b0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-59745-157-4_3","article-title":"Methods for assessing autophagy and autophagic cell death","volume":"445","author":"Tasdemir","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cyto.2021.155432_b0290","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/jid.2013.165","article-title":"Autophagy has a significant role in determining skin color by regulating melanosome degradation in keratinocytes","volume":"133","author":"Murase","year":"2013","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0295","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jid.2017.06.033","article-title":"Vitiligo skin: exploring the dermal compartment","volume":"138","author":"Kovacs","year":"2018","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.cyto.2021.155432_b0300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000056152","article-title":"Oxidative stress induced cytokine production in isolated rat pancreatic acinar cells: effects of small-molecule antioxidants","volume":"64","author":"Seo","year":"2002","journal-title":"Pharmacol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:59:09Z","timestamp":1760907549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":60,"alternative-id":["S1043466621000120"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155432","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155432"}}